Literature DB >> 16263170

The catalytic activity of REV1 is employed during immunoglobulin gene diversification in DT40.

Anna-Laura Ross1, Julian E Sale.   

Abstract

REV1 plays a key role in vertebrate translesion synthesis. Although its deoxycytidyl transferase activity is dispensable for tolerance of DNA damage caused by a number of mutagens, its extreme C terminus, which interacts with other translesion polymerases and PCNA, is essential. By examining immunoglobulin diversification in the genetically tractable chicken cell line DT40 we show that the generation of non-templated point mutations from C/G to G/C does require the catalytic activity of REV1. This provides the first clear evidence that the catalytic activity of REV1 is utilised in vivo in higher eukaryotes and is involved in immunoglobulin diversification. Although rev1 DT40 cells incorporate few point mutations, a mutant lacking the C terminus of REV1 exhibits a similar level to that seen in wild-type cells. Thus, the polymerase selection or stabilisation role of REV1 does not appear to play a major role in the bypass of AID-dependent abasic sites.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16263170     DOI: 10.1016/j.molimm.2005.09.017

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  45 in total

1.  The critical mutagenic translesion DNA polymerase Rev1 is highly expressed during G(2)/M phase rather than S phase.

Authors:  Lauren S Waters; Graham C Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-02       Impact factor: 11.205

2.  p21 is dispensable for AID-mediated class switch recombination and mutagenesis of immunoglobulin genes during somatic hypermutation.

Authors:  Maryam Shansab; Erik Selsing
Journal:  Mol Immunol       Date:  2011-02-01       Impact factor: 4.407

3.  What a difference a decade makes: insights into translesion DNA synthesis.

Authors:  Wei Yang; Roger Woodgate
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-26       Impact factor: 11.205

Review 4.  Timing matters: error-prone gap filling and translesion synthesis in immunoglobulin gene hypermutation.

Authors:  Julian E Sale; Christopher Batters; Charlotte E Edmunds; Lara G Phillips; Laura J Simpson; Dávid Szüts
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-03-12       Impact factor: 6.237

Review 5.  Hijacked DNA repair proteins and unchained DNA polymerases.

Authors:  Huseyin Saribasak; Deepa Rajagopal; Robert W Maul; Patricia J Gearhart
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-03-12       Impact factor: 6.237

6.  Effects of Twelve Germline Missense Variations on DNA Lesion and G-Quadruplex Bypass Activities of Human DNA Polymerase REV1.

Authors:  Mina Yeom; In-Hyeok Kim; Jae-Kwon Kim; KyeongJin Kang; Robert L Eoff; F Peter Guengerich; Jeong-Yun Choi
Journal:  Chem Res Toxicol       Date:  2016-03-04       Impact factor: 3.739

Review 7.  Controlling somatic hypermutation in immunoglobulin variable and switch regions.

Authors:  Robert W Maul; Patricia J Gearhart
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

8.  Two distinct translesion synthesis pathways across a lipid peroxidation-derived DNA adduct in mammalian cells.

Authors:  In-Young Yang; Keiji Hashimoto; Niels de Wind; Ian A Blair; Masaaki Moriya
Journal:  J Biol Chem       Date:  2008-11-03       Impact factor: 5.157

9.  DNA polymerases nu and theta are required for efficient immunoglobulin V gene diversification in chicken.

Authors:  Masaoki Kohzaki; Kana Nishihara; Kouji Hirota; Eiichiro Sonoda; Michio Yoshimura; Shigeo Ekino; John E Butler; Masami Watanabe; Thanos D Halazonetis; Shunichi Takeda
Journal:  J Cell Biol       Date:  2010-06-28       Impact factor: 10.539

10.  Dependence of nucleotide substitutions on Ung2, Msh2, and PCNA-Ub during somatic hypermutation.

Authors:  Peter H L Krijger; Petra Langerak; Paul C M van den Berk; Heinz Jacobs
Journal:  J Exp Med       Date:  2009-11-09       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.